Oba K et al., 2007-06: Meta-analysis of eight centrally randomised trials (8,009 patients) of adjuvant PSK with chemotherapy after curative gastric cancer resection: overall hazard ratio 0.88, no significant heterogeneity.
The overall hazard ratio for eligible patients was 0.88 (95% confidence interval, 0.79-0.98; P = 0.018) with no significant heterogeneity
Abstract
Oba K et al., 2007-06: Meta-analysis of eight centrally randomised trials (8,009 patients) of adjuvant PSK with chemotherapy after curative gastric cancer resection: overall hazard ratio 0.88, no significant heterogeneity. Study type: review.
